Cellenkos Approved to Proceed with CK0803 Neurotrophic T reg

/PRNewswire/ -- Cellenkos® today announced encouraging safety data from its innovative CK0803 neurotrophic T regulatory (Treg) cell therapy, being developed to...

Related Keywords

Houston , Texas , United States , New York , Baylor College Of Medicine , Columbia University , Tara Sadeghi , Prnewswire Cellenkos , Cellenkos Inc , Michaele Debakey Va Medical Center , National Institute Of Neurological Disorders , Amyotrophic Lateral Sclerosis , Data Safety Monitoring Board , Chief Operating Officer , Run In Study , Double Blind , Placebo Control Trial , Baylor College , Rating Scale Revised , National Institute , Neurological Disorders , Cellenkos , Nc ,